SAN FRANCISCO — Medicaid programs in Delaware, Maryland, New Jersey, and Pennsylvania denied nearly half of all claims in recent months for direct-acting antiviral hepatitis C drugs, according to an ...

Researchers from the University of Texas MD Anderson Cancer Center in Houston have found the cost of treating people with hepatitis C virus with newly approved therapies may cost the country’s health ...

Louisiana is communicating with CMS to explore a subscription-based payment model for hepatitis C treatments, according to a proposal the Louisiana Department of Health released this week. The health ...

Shares of two biotechnology companies jumped yesterday after they reported some of the best results ever seen in treatment of a serious liver virus, the latest indication that a cure for hepatitis C ...

Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...

SILVER SPRING, Maryland (Reuters) - A Merck & Co drug that boosts the chance of curing hepatitis C infection moved closer to the U.S. market on Wednesday as an advisory panel unanimously recommended ...

New Haven drug developer Achillion Pharmaceuticals Inc. has launched its first human trial of one of its treatment for chronic hepatitis C. The company says the double-blind Phase 1 study of its ...

LONDON (Reuters) - Frustrated by the high price of antiviral drugs, thousands of patients from London to Moscow to Sydney are turning to a new wave of online "buyers clubs" to get cheap generic ...